Blog

10 December, 2025

The first fast track for multinational clinical trials in Europe will start in January 2026 and will help strengthen European competitiveness in this area.

The Spanish Agency for Medicines and Health Products has been one of the driving forces behind this accelerated assessment procedure, which will provide trial sponsors with […]
10 November, 2025

“Distefar, highly conscious of the environment, welcomes and echoes the environmental transformation that the pharmaceutical industry is undergoing towards sustainability.”

The goal of net zero emissions is a global commitment shared by many industries, including pharmaceuticals. However, the path to true sustainability goes beyond simple regulatory […]
14 October, 2025

“Spain has a great opportunity in the biopharmaceutical sector, but it must review its policies to maintain and increase its potential and attract investment in R&D and in industrial and digital assets.”

The president of Farmaindustria, Fina Lladós, calls for a regulatory framework that improves the country’s competitiveness in order to turn the current situation of global uncertainty […]
7 October, 2025

Spain consolidates its leadership in clinical trials with new guidelines promoting innovation, digitalisation and sustainability in hospital pharmacy

Pharmacists and industry present the updated “Guide to Excellence for Conducting Clinical Trials in Hospital Pharmacy” in Barcelona. This is another step towards excellence and improving […]
16 September, 2025

Farmaindustria welcomes the announcement by the Spanish Agency for Medicines and Health Products (AEMPS) to expand the accelerated assessment of early-stage clinical trials, as this strengthens the Spanish biomedical research ecosystem.

This “fast track” is one of the sector’s strategic measures in the field of biomedical research and is included in the National Pharmaceutical Industry Strategy. Patients […]
23 May, 2025

An appropriate regulatory framework and more impetus for innovation, key to increasing competitiveness in biomedical research

The XVIII Conference of Biomedical Research Technology Platforms brings together in Madrid more than 200 representatives from public administrations, regulatory agencies, universities and companies to analyse […]